These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4966174)

  • 1. [Basic study on the antibacterial power of 1321 TH].
    Ogawa M
    Saishin Igaku; 1967 Sep; 22(9):2058-65. PubMed ID: 4966174
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the antibacterial power of 1321 Th in vitro and its antibacterial action in combination with antitubercular agents (secondary)].
    Yamazaki M
    Saishin Igaku; 1967 Sep; 22(9):2083-6. PubMed ID: 4966176
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of antituberculous action in vitro and in vivo between 1321 Th and 1314 Th].
    Kanai K; Koseki U; Okamoto S; Murohashi T
    Saishin Igaku; 1967 Sep; 22(9):2053-7. PubMed ID: 4966173
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison between antituberculous activity of alpha-ethyl-thioisonicotinamide (1314 TH) and alpha-N-propylthioisonicotinamide (1321 TH) in vitro].
    Tamura M; Takano S
    Kekkaku; 1971 May; 46(5):137-52. PubMed ID: 4996120
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of the susceptibility to ethionamide and isoniazid of tubercle bacilli from patients never treated with ethionamide.
    Hok TT; Seng TK
    Paediatr Indones; 1967; 7(1):32-8. PubMed ID: 4963150
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antitubercular effect of ethionamide in vitro and in experimental tuberculosis].
    Bialik IB
    Mikrobiol Zh; 1966; 28(5):65-70. PubMed ID: 4966793
    [No Abstract]   [Full Text] [Related]  

  • 7. [Criteria of mycobacterium resistance to thioacetazone and cross resistance to ethionamide].
    Afanas'eva IuP; Mkrtchian SV
    Probl Tuberk; 1969; 47(3):66-9. PubMed ID: 4982181
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimycobacterial activity of ethionamide on the tubercle bacilli in a semisolid Dubos agar medium].
    Okamoto K; Terunuma K
    Kekkaku; 1967 Dec; 42(12):489-94. PubMed ID: 4970608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental and clinical evaluation of alpha-propyl-2-thioisonicotinamide (1321 TH)].
    Kawamori U; Soejima R; Tagawa K; Nagao T; Nozute H
    Saishin Igaku; 1967 Sep; 22(9):2066-72. PubMed ID: 4966175
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)].
    Hayashi S
    Kumamoto Igakkai Zasshi; 1970 Feb; 44(2):135-43. PubMed ID: 4986047
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reinforcement in vitro of the antibacillary action of ethionamide (2-ethyl isonicotinic acid thioamide, 1314 Th) and of prothionamide (alpha-propyl-isonicotinic acid thioamide, 1321 Th) by sodium pyruvate].
    Coletsos P
    C R Acad Hebd Seances Acad Sci D; 1967 Oct; 265(17):1263-5. PubMed ID: 4965553
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antituberculous action and clinical effects of alpha-propyl-thioisonicotinamide (1321 TH)].
    Yamamoto K; Sakurai H; Inoue I; Sasaoka M; Hashimoto T
    Saishin Igaku; 1967 Sep; 22(9):2087-97. PubMed ID: 4966177
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 14. The ethionamide sensitivity of British pre-treatment strains of Mycobacterium tuberculosis.
    Lefford MJ
    Tubercle; 1966 Jun; 47(2):198-206. PubMed ID: 4960414
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide.
    Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
    J Antimicrob Chemother; 2004 Apr; 53(4):600-3. PubMed ID: 14973155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methods for testing the sensitivity of Mycobacterium tuberculosis to ethionamide.
    Lefford MJ; Mitchison DA
    Tubercle; 1966 Sep; 47(3):250-61. PubMed ID: 4961602
    [No Abstract]   [Full Text] [Related]  

  • 17. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
    Okamoto K; Watanabe S; Terunuma K
    Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the 1314TH resistant media].
    Hayashi N; Inada S; Kobayashi H; Hara M; Yamagiwa N
    Iryo; 1969 Feb; 23(2):179-82. PubMed ID: 4979517
    [No Abstract]   [Full Text] [Related]  

  • 20. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D
    Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.